{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03684018",
            "orgStudyIdInfo": {
                "id": "IgPro10_4002"
            },
            "secondaryIdInfos": [
                {
                    "id": "2018-003430-33",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "CSL Behring",
                "class": "INDUSTRY"
            },
            "briefTitle": "Two Dose Levels of Privigen in Pediatric CIDP",
            "officialTitle": "Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP",
            "therapeuticArea": [
                "Immunology and Rheumatology"
            ],
            "study": "two-dose-levels-of-privigen-in-pediatric-cidp"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-02-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-12-20",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-12-20",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-09-24",
            "studyFirstSubmitQcDate": "2018-09-24",
            "studyFirstPostDateStruct": {
                "date": "2018-09-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "CSL Behring",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to \u2264 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment"
        },
        "conditionsModule": {
            "conditions": [
                "Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "IgPro10 (dose level 1)",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Biological: IgPro10"
                    ]
                },
                {
                    "label": "IgPro10 (dose level 2)",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Biological: IgPro10"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "IgPro10",
                    "description": "Normal human immunoglobulin G administered intravenously",
                    "armGroupLabels": [
                        "IgPro10 (dose level 1)",
                        "IgPro10 (dose level 2)"
                    ],
                    "otherNames": [
                        "Privigen"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage (%) of subjects with CIDP relapse in the Randomized Phase by dose level",
                    "description": "CIDP relapse, defined as a clinical decline relative to the previous assessment as indicated by an increase in modified Rankin Scale (mRS) of \u2265 1 point, in the Randomized Phase",
                    "timeFrame": "Approximately 24 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percentage of subjects with treatment emergent adverse events (TEAEs) by dose level",
                    "timeFrame": "Approximately 56 weeks"
                },
                {
                    "measure": "Rate of TEAEs per infusion",
                    "timeFrame": "Approximately 56 weeks"
                },
                {
                    "measure": "Rate of mild, moderate, and severe TEAEs per infusion by dose level",
                    "timeFrame": "Approximately 56 weeks"
                },
                {
                    "measure": "Percentage of subjects with serious TEAEs",
                    "timeFrame": "Approximately 56 weeks"
                },
                {
                    "measure": "Rate of serious TEAEs per infusion",
                    "timeFrame": "Approximately 56 weeks"
                },
                {
                    "measure": "Percentage of subjects with related TEAEs",
                    "timeFrame": "Approximately 56 weeks"
                },
                {
                    "measure": "Rate of related TEAEs per infusion",
                    "timeFrame": "Approximately 56 weeks"
                },
                {
                    "measure": "Percentage of subjects with CIDP relapse in the Dose Exploration Phase by dose level assigned in the Randomized Phase",
                    "timeFrame": "Approximately 24 weeks"
                },
                {
                    "measure": "Change in modified Rankin Scale (mRS) score from baseline in the Randomized Phase",
                    "description": "The mRS is a disability scale ranging from 0 (asymptomatic) to 6 (death)",
                    "timeFrame": "Baseline and Approximately 24 weeks"
                },
                {
                    "measure": "Percentage (%) of subjects with CIDP improvement in the Randomization Phase by dose level",
                    "description": "CIDP improvement in the Randomized Phase, defined as a decrease in mRS score \u2265 1 from previous visit",
                    "timeFrame": "Approximately 24 weeks"
                },
                {
                    "measure": "Percentage (%) of subjects with CIDP recovery in the Randomization Phase by dose level",
                    "description": "CIDP recovery in the Randomized Phase, defined as decrease in mRS score as comparedto baseline AND mRS score of 1 or 0 at end of Randomized Phase",
                    "timeFrame": "Approximately 24 weeks"
                },
                {
                    "measure": "Time to CIDP relapse in Randomized Phase by dose level",
                    "timeFrame": "Approximately 24 weeks"
                },
                {
                    "measure": "Percentage (%) of subjects with CIDP improvement in the Dose Exploration Phase (DEP) by dose level",
                    "description": "CIDP improvement in the Dose Exploration Phase, defined as decrease in mRS score \u2265 1 from baseline",
                    "timeFrame": "Approximately 24 weeks"
                },
                {
                    "measure": "Percentage (%) of subjects with CIDP recovery in the Dose Exploration Phase by dose level",
                    "description": "CIDP recovery in the Dose Exploration Phase, defined as decrease in mRS score compared to baseline AND mRS score of 1 or 0 at end of DEP",
                    "timeFrame": "Approximately 24 weeks"
                },
                {
                    "measure": "Time to CIDP Relapse in the Dose Exploration Phase by dose level",
                    "timeFrame": "Approximately 24 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female subjects 2 to \u2264 17 years of age with confirmed or possible CIDP.\n\nExclusion Criteria:\n\n* Absence of CIDP symptoms\n* History or family history of inherited neuropathy\n* Diagnosed developmental delay or regression\n* History of thrombotic episode\n* Known or suspected hypersensitivity to Privigen\n* Known allergic or other severe reactions to blood products\n* Female subject of childbearing potential either not using or not willing to use a medically reliable method of contraception or not sexually abstinent during the study\n* Pregnant or breastfeeding mother\"",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "2 Years",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Trial Registration Coordinator",
                    "role": "CONTACT",
                    "phone": "610-878-4000",
                    "email": "clinicaltrials@cslbehring.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Study Director",
                    "affiliation": "CSL Behring",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Phoenix Children's Hospital",
                    "status": "COMPLETED",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85016",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Children's Hospital of Los Angeles",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90027",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of Iowa Hospitals and Clinics",
                    "status": "WITHDRAWN",
                    "city": "Iowa City",
                    "state": "Iowa",
                    "zip": "52242-1009",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.66113,
                        "lon": -91.53017
                    }
                },
                {
                    "facility": "Akron Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Akron",
                    "state": "Ohio",
                    "zip": "44647",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.08144,
                        "lon": -81.51901
                    }
                },
                {
                    "facility": "Children's Hospital of Philadelphia",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Le Bonheur Children's Hospital",
                    "status": "WITHDRAWN",
                    "city": "Memphis",
                    "state": "Tennessee",
                    "zip": "38105",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.14953,
                        "lon": -90.04898
                    }
                },
                {
                    "facility": "Neurology Rare Disease Center",
                    "status": "RECRUITING",
                    "city": "Denton",
                    "state": "Texas",
                    "zip": "76208",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.21484,
                        "lon": -97.13307
                    }
                },
                {
                    "facility": "Children's Specialty Group",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23507",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Canada"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011115",
                    "term": "Polyneuropathies"
                },
                {
                    "id": "D000020277",
                    "term": "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010523",
                    "term": "Peripheral Nervous System Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000011129",
                    "term": "Polyradiculoneuropathy"
                },
                {
                    "id": "D000020274",
                    "term": "Autoimmune Diseases of the Nervous System"
                },
                {
                    "id": "D000003711",
                    "term": "Demyelinating Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13999",
                    "name": "Polyneuropathies",
                    "asFound": "Polyneuropathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22097",
                    "name": "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",
                    "asFound": "Chronic Inflammatory Demyelinating Polyneuropathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14013",
                    "name": "Polyradiculoneuropathy",
                    "relevance": "LOW"
                },
                {
                    "id": "M13432",
                    "name": "Peripheral Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22094",
                    "name": "Autoimmune Diseases of the Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M6909",
                    "name": "Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T1306",
                    "name": "Chronic Inflammatory Demyelinating Polyneuropathy",
                    "asFound": "Chronic Inflammatory Demyelinating Polyneuropathy",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016756",
                    "term": "Immunoglobulins, Intravenous"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M10122",
                    "name": "Immunoglobulin G",
                    "relevance": "LOW"
                },
                {
                    "id": "M19117",
                    "name": "Immunoglobulins, Intravenous",
                    "asFound": "Tomotherapy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8836",
                    "name": "gamma-Globulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M20191",
                    "name": "Rho(D) Immune Globulin",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}